ConcertAI

ConcertAI accelerates advancements in translational medicine, clinical trials, clinical development, imaging, diagnostics, commercial insights, and oncology care. Their new PRECISIONSUITE offers AI and real-world data (RWD) solutions tailored for life science enterprises.

Utilizing the power of CARAai™ and ConcertAI's integrated oncology data, they deliver enterprise-wide value to life sciences customers. Their offerings span from discovery to delivery, unifying real-world data, AI innovation, and clinical expertise to drive breakthroughs across life sciences and healthcare.

Key solutions include:

• Oncology data for therapeutic insights and digital trial solutions.
• AI solutions that accelerate clinical trials and commercial solutions.
• Data and AI for improved patient outcomes through CancerLinQ®.
• AI visualization for medical imaging with TeraRecon.

ConcertAI provides comprehensive, oncology-focused data and services to help life science organizations better understand the therapy landscape. Their solutions enable sponsors to accelerate and de-risk clinical trials through improved study timelines and more effective patient recruitment.

They offer patient-centric data aggregation and AI-driven assistants designed to optimize patient outcomes and drive brand success. SmartLinQ™ delivers real-time clinical insights, quality measure tracking, and trial screening support.

Their AI-powered medical interpretation software reduces cognitive burden and enhances decision-making for healthcare providers. ConcertAI's solutions are powered by deep, broad, multi-modal real-world data, supporting life science and healthcare clients with cutting-edge insights and tools.